APA (7th ed.) Citation

I, D., A, M., N, J., NZ, G., FJ, F., A, F., . . . JK, L. (2023). Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib. JCO oncology practice, 19(9), 786. https://doi.org/10.1200/OP.23.00031

Chicago Style (17th ed.) Citation

I, Dagogo-Jack, et al. "Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib." JCO Oncology Practice 19, no. 9 (2023): 786. https://doi.org/10.1200/OP.23.00031.

MLA (9th ed.) Citation

I, Dagogo-Jack, et al. "Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib." JCO Oncology Practice, vol. 19, no. 9, 2023, p. 786, https://doi.org/10.1200/OP.23.00031.